BAYLOR SCOTT & WHTIE CONTINUING CARE — History
CCN 452105 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$14M
Latest Revenue (FY2022)
-1.7%
Revenue CAGR (3yr)
-63.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $10M | $14M | +40.9% | -1.7% |
| Operating Expenses | $20M | $22M | $23M | +5.4% | +5.9% |
| Operating Margin | -40.8% | -100.0% | -63.4% | +36.6% | +0.0% |
| Net Income | $-6M | $-12M | $-9M | +24.7% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 7,397 | 6,415 | 7,393 | +15.2% | -0.0% |
| Medicare Day % | 30% | 34% | 30% | -13.3% | -1.5% |
| Medicaid Day % | 3% | 2% | 1% | -55.5% | -35.0% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -3.4% ($15M → $14M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.7%
This Hospital
+7.6%
State Avg
Latest Margin
-63.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | -74.6% |
| FY2024 (proj) | $14M | -85.9% |
| FY2025 (proj) | $13M | -97.2% |